T1	Participants 242 302	children with autism spectrum disorders (ASD) ages 3-8 years
T2	Participants 329 388	65 children with ASD who received one round of DMSA (3 days
T3	Participants 391 450	Participants who had high urinary excretion of toxic metals
T4	Participants 504 567	49 participants were randomly assigned in a double-blind design